drugset / Trial / NCT00276133

Effects of Atorvastatin Versus Probucol on Small Dense LDL

NCT00276133

Phase 4 Completed 24 enrolled Yokohama City University Medical Center
RandomizedCrossoverOpen-labelTreatment

Summary

Small dense low-density lipoprotein (LDL) plays an important role in causing glomerular injury through conversion to an oxidatively modified form of LDL. However, few studies evaluated the effects of antilipidemic agents on the LDL particle size and renoprotective actions in hyperlipidemic patients with non-diabetic nephropathy.

Timeline

Start
2004-01
Primary completion
Completion
2007-05

Drugs

EvaluationDrugModalityDoseRoute
Subject Atorvastatin Small molecule 10 mg
Subject Probucol Small molecule 500 mg